Private Wealth Management interview preparation

Questions

100

Traced to a firm

22

Firms

13

Updated

September 2026

Asked at

All firmsAllianceBernstein4Goldman Sachs4Northern Trust3J.P. Morgan2MSMorgan Stanley2Scotiabank2AMAres Management1BMBNY Mellon1Carlyle Group1Invesco1Neuberger Berman1SCSchroders1UBS1

Topic

All topicsClient discovery5Risk profiling4Asset allocation and rebalancing7Investment policy statement3Tax and asset location6Concentrated positions3Estate, succession and philanthropy6Fiduciary and trusts3Alternatives and liquidity4Products and platforms7Fees and conflicts4Bank economics and risk2Behavioural finance3Family governance3Onboarding and compliance3Business development6Fit and career15Markets and economy9Case and estimation7

Level

AnyCoreIntermediateHard

Type

AnyTechnicalCaseMarket viewFitBrainteaser

1. 051Where are the conflicts of interest inside a private bank, and how are they managed?Fees and conflictsHardsuperdayPrivate bankingWealth management

   Say this

   Three main ones: product manufacturing, where the bank earns more on its own funds; balance sheet, where lending to the client is more profitable than advising him to deleverage; and cross-referral, where the wealth relationship feeds the investment bank. They are managed by disclosure, supervision and open architecture, imperfectly.

   Then walk it

   1. In-house product. If the bank runs its own funds, structured notes and discretionary portfolios, the revenue on those is several times the revenue on a third-party index fund. The control is open architecture with documented selection criteria and a best-execution or best-selection policy, plus monitoring of in-house share.
   2. The balance sheet conflict is the underrated one. A Lombard loan against the client's portfolio is highly profitable and low risk to the bank, and it also increases the client's risk. An adviser paid on revenue has every incentive to encourage leverage, and no incentive to tell a client to repay his mortgage instead of investing.
   3. Distribution incentives. Upfront commission on insurance and structured products can be multiples of the trail on a mutual fund, which biases what gets pitched at quarter end. Controls are product governance committees, a target market definition per product, and sales incentive design that is not purely revenue-linked.
   4. Cross-divisional conflicts. The private bank knows a client is selling his company; the investment bank wants the mandate; the research desk has a view on a stock the client holds. Information barriers, restricted lists and control-room clearance exist for exactly this.
   5. Then the conflicts around the adviser himself: book transfers, discretionary bonus, and the fact that a relationship manager who leaves may take clients with him. That is why banks separate the client relationship from the individual and why clients often feel like the bank's asset rather than the adviser's.
   6. How well it works, honestly: disclosure is weak medicine, because clients do not read it and consent does not remove the incentive. Structural measures work better, salary and quality-based bonuses rather than revenue share, in-house product caps, and a documented suitability trail. Credit Suisse and others have shown that where incentives and controls diverge, incentives win.

   Where candidates lose it

   Answering only with 'we disclose it' or 'there are Chinese walls'. The strong answer names the balance sheet conflict, which most candidates miss entirely, and admits that disclosure alone does not fix incentives. Interviewers at banks respect that more than a compliance recital.

   Expect next

   • How would you handle a client who wants to borrow to invest?
   • What is open architecture and is it real?
   • How should a relationship manager be paid?
2. 052Your firm's in-house fund pays you twice what an index fund does, and the index fund suits the client better. What do you do?Fees and conflictsHardsuperdayPrivate bankingIndian wealth management

   Say this

   Recommend the index fund. But I would not pretend the decision is costless: I would document the comparison, disclose the economics if the client asks, and if the firm's policy pushed me the other way I would escalate rather than quietly comply.

   Then walk it

   1. Start from the standard that applies. If I owe a fiduciary duty, this is not a judgement call, it is the duty. Even under a suitability standard, recommending the more expensive of two equivalent products because it pays me more is indefensible if the file is ever reviewed.
   2. Do the comparison properly rather than assuming. Sometimes the in-house product genuinely is better: access, a strategy that is not otherwise available, lower all-in cost because of a fee waiver. If so, document why and the recommendation is fine. The failure is not using in-house product, it is not testing it.
   3. Document the basis of the recommendation, because that document is what protects both the client and me. What I compared, on what criteria, why I chose what I chose.
   4. Say it out loud in the interview: I would rather lose the revenue on one recommendation than have a suitability file that cannot be defended. One mis-sold product, found years later, costs more than the fee it earned, and in this industry the regulator looks backwards.
   5. If there is institutional pressure, a house model portfolio or a sales target that effectively mandates the in-house fund, the answer is to raise it with a manager and with compliance, in writing. Not to argue it out with a client in the meeting.
   6. And the pragmatic note that keeps this from sounding naive: in most real cases the answer is a blend that satisfies the house model while keeping the core in low-cost index exposure. The choice is rarely as binary as the question makes it, and finding the version that works for both is the actual skill.

   Where candidates lose it

   Two failure modes. The self-righteous answer that shows no awareness that revenue matters to the firm, and the compliant answer that says you would follow the house model. The interviewer wants to hear the documented comparison, the willingness to escalate in writing, and an awareness that the decision has a cost.

   Expect next

   • What if your manager tells you to sell the in-house fund anyway?
   • Would you disclose your compensation to the client unprompted?
   • When is an in-house product the right recommendation?

Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.